Skip to main content

Advertisement

SpringerLink
Log in

Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Chronic anal fissure (CAF) is a common problem that causes significant morbidity. Little is known about the risk factors of CAF among patients with inflammatory bowel disease (IBD).

Aim

To study the clinical characteristics and prevalence of CAF among a cohort of IBD patients.

Methods

We performed a population-based study on IBD patients from the National Veterans Affairs administrative datasets from 1998 to 2011. IBD and AF were identified by ICD-9 diagnosis codes.

Results

We identified 60,376 patients with IBD between the ages of 18–90 years, 94 % males, 59 % diagnosed with ulcerative colitis (UC), and 88 % were Caucasians. The overall prevalence of CAF was 4 % for both males and females. African Americans (AA) were two times more likely to have CAF compared to Caucasians (8 vs. 4 %; OR 2.0, 95 % CI 1.6–20.2, p = 0.0001) or Hispanics (8 vs. 4.8 %; OR 2.1, 95 % CI 1.4–25.2, p = 0.0001). The prevalence of CAF significantly dropped with age from 7 % at age group 20–50 to 1.5 % at 60–90 (p = 0.0001). CD patients were two times more likely to have CAF than UC patients (6 vs. 3 %; OR 1.9, 95 % CI 1.5–18.2, p = 0.0001). The initial diagnosis of CAF occurred within 14 years after the initial diagnosis of IBD in 74.5 % patients.

Conclusions

CAF is more prevalent among IBD than what is reported in the general population and diagnosed after the diagnosis of IBD. CAF is more prevalent among patients with CD, younger patients, and AA. The current results lay the groundwork for further outcome studies relate to anal fissure such as utilization, hospitalization, and cost.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Madalinski MH. Identifying the best therapy for chronic anal fissure. World J Gastrointest Pharmacol Ther. 2011;14:9–16.

    Article  Google Scholar 

  2. Zaghiyan KN, Fleshner P. Anal fissure. Clin Colon Rectal Surg. 2011;14:22–30.

    Article  Google Scholar 

  3. Lindsey I, Jones OM, Cunningham C, George BD, Mortensen NJ. Botulinum toxin as second-line therapy for chronic anal fissure failing 0.2 percent glyceryl trinitrate. Dis Colon Rectum. 2003;46:361–366.

    Article  PubMed  Google Scholar 

  4. Wollina U. Pharmacological sphincterotomy for chronic anal fissures by botulinum toxin a. J Cutan Aesthet Surg. 2008;1:58–63.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Medhi B, Rao RS, Prakash A, Prakash O, Kaman L, Pandhi P. Advances in the pharmacotherapy of chronic anal fissure: an update. Asian J Surg. 2008;3:154–163.

    Article  Google Scholar 

  6. Mapel DM, Schum M, Worley AV. The epidemiology and treatment of anal fissures in a population-based cohort. BMC Gastroenterol. 2014;14:1–7.

    Article  Google Scholar 

  7. Lund JN, Scholefield JH. Etiology and treatment of anal fissure. Br J Surg. 1996;83:1335–1344.

    Article  PubMed  CAS  Google Scholar 

  8. Williams DR, Coller JA, Corman ML, Nugent FW, Veidenheimer MC. Anal complications in Crohn’s disease. Dis Colon Rectum. 1981;24:22–24.

    Article  PubMed  CAS  Google Scholar 

  9. Sweeney JL, Ritchie JK, Nicholls RJ. Anal fissure in Crohn’s disease. Br J Surg. 1988;75:56–57.

    Article  PubMed  CAS  Google Scholar 

  10. Fleshner PR, Schoetz DJ Jr, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC. Anal fissure in Crohn’s disease: a plea for aggressive management. Dis Colon Rectum. 1995;38:1137–1143.

    Article  PubMed  CAS  Google Scholar 

  11. Hou JK, Tan M, Stidham RW, et al. Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn’s disease in the Veterans Affairs Health Care System. Dig Dis Sci. 2014;59:2406–2410.

    Article  PubMed  CAS  Google Scholar 

  12. Isene R, Bernklev T, Høie O, et al. Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol. 2015;50:300–305.

    Article  PubMed  Google Scholar 

  13. Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–119.

    Article  PubMed  Google Scholar 

  14. Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20:213–227.

    Article  PubMed  Google Scholar 

  15. Siegel CA, MacDermott RP. Is chronic pain an extraintestinal manifestation of IBD? Inflamm Bowel Dis. 2009;15:769–771.

    Article  PubMed  Google Scholar 

  16. Sofia MA, Rubin DT, Hou N, Pekow J. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital. Dig Dis Sci. 2014;59:2228–2235.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Lin KK, Sewell JL. The effects of race and socioeconomic status on immunomodulator and anti-tumor necrosis factor use among ambulatory patients with inflammatory bowel disease in the United States. Am J Gastroenterol. 2013;108:1824–1830.

    Article  PubMed  Google Scholar 

  18. Sewell JL, Inadomi JM, Yee HF Jr. Race and inflammatory bowel disease in an urban healthcare system. Dig Dis Sci. 2010;55:3479–3487.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Nguyen GC, LaVeist TA, Harris ML, Wang MH, Datta LW, Brant SR. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol. 2010;105:2202–2208.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Nguyen GC, Munsell M, Brant SR, LaVeist TA. Racial and geographic disparities in the use of parenteral nutrition among inflammatory bowel disease inpatients diagnosed with malnutrition in the United States. J Parenter Enteral Nutr. 2009;33:563–568.

    Article  Google Scholar 

  21. Flasar MH, Johnson T, Roghmann MC, Cross RK. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2008;14:13–19.

    Article  PubMed  Google Scholar 

  22. Sainio P. Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Ann Chir Gynnaecol. 1984;73:219–224.

    CAS  Google Scholar 

  23. Abramowitz L, Batallan A. Epidemiology of anal lesions (fissure and thrombosed external hemorrhoid) during pregnancy and post-partum]. Gynecol Obstet Fertil. 2003;31:546–549.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This project was supported by a grant from Aptalis Pharm.

Author information

Authors and Affiliations

  1. Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Hoda M. Malaty & Jason K. Hou

  2. VA HSR&D Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA

    Shubhada Sansgiry & Jason K. Hou

  3. Department of Surgery, Baylor College of Medicine, Houston, TX, USA

    Avo Artinyan

Authors
  1. Hoda M. Malaty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shubhada Sansgiry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Avo Artinyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jason K. Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hoda M. Malaty.

Ethics declarations

Conflict of interest

All the authors listed on the manuscript take full responsibility for the manuscript. There is no potential conflict of interest, real or perceived on submitting that manuscript. There are no prior publications or submissions of with any overlapping information.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malaty, H.M., Sansgiry, S., Artinyan, A. et al. Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci 61, 861–864 (2016). https://doi.org/10.1007/s10620-015-3930-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3930-3

Keywords

Search

Navigation